Home/MitoRx Therapeutics/Prof. Matt Whiteman
PM

Prof. Matt Whiteman

Chief Scientific Officer (CSO) and Co-founder

MitoRx Therapeutics

MitoRx Therapeutics Pipeline

DrugIndicationPhase
Intermittent Injectable ProgramObesityPreclinical
Oral ProgramObesityPreclinical